Armando Ramirez։ Key Takeaways from NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia
Armando Ramirez, US Sales and Business Development Director at GENinCode Predictive Genetics, shared a National Lipid Association post on LinkedIn, adding:
”This is huge…
Here are some of my takeaways:
- Earlier identification through universal pediatric screening, opportunistic adult screening, and systematic cascade testing of families – this is a positive step forward.
- Genetic testing as a powerful complement to clinical diagnosis and family screening (not a barrier to treatment) – as a speciality, we need to be screening more.
- More aggressive LDL-C targets (often <70 mg/dL for primary prevention, <55 mg/dL for secondary prevention) – this will lead to better outcomes.
FH is one of the most preventable causes of premature heart disease. I feel this update moves us closer to proactive, precision-driven, family-centered prevention.”
Quoting National Lipid Association՛s post:
”NOW AVAILABLE: The NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia (FH)
This updated expert clinical consensus on FH reflects more than a decade of advances in screening, diagnosis, and treatment.
- Read the full consensus statement.
- Watch our CME-accredited video podcast with key authors.
- View the press release․
Title: Update on familial hypercholesterolemia: an expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Read the Full Article on Journal of Clinical Lipidology.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 27, 2026, 14:53Tooba Rehman: Extending Impella 5.5 Support Beyond 14 Days in Cardiogenic Shock
-
Mar 26, 2026, 17:33Melissa Bouchard: Navigating Prosthetic Valves and Anticoagulation in Pregnancy at ACHD Hive Talks
-
Mar 26, 2026, 17:25Yonah S. Tehrani: Providing Clarity for Anticoagulant Selection in Acute Venous Thromboembolism
-
Mar 26, 2026, 17:18Casey Laycock: Spotlight on Community Champion – Jon Schneider of Spire
-
Mar 26, 2026, 17:16Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease
-
Mar 26, 2026, 17:15Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
-
Mar 26, 2026, 17:14Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation
-
Mar 26, 2026, 17:03Tilden Sokoloff: PRP Injections Enhance Sexual Function in Premenopausal Women
-
Mar 26, 2026, 17:02Mahesan Subramaniam: Japan Brings Mitochondrial Therapy to the Frontline of Cardiology